The Rs 30.24 crore IPO, which comprised entirely a fresh issue of 14.54 lakh shares, witnessed overwhelming investor interest during the three-day bidding period. The issue was subscribed 385.32 times, driven by robust participation across all investor categories.
The Rs 30.24 crore IPO, which comprised entirely a fresh issue of 14.54 lakh shares, witnessed overwhelming investor interest during the three-day bidding period. The issue was subscribed 385.32 times, driven by robust participation across all investor categories.
<iframe src="https://hindustansphere.com/embed/cluster/90d6d484c12ed0ecb365312cff91dca4886ce0c7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Avience Biomedicals shares may make a strong debut as GMP signals 62% premium ahead of listing"></iframe>
